These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32126235)

  • 1. Non-lipid II targeting lantibiotics.
    Wang X; Gu Q; Breukink E
    Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183244. PubMed ID: 32126235
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm.
    Okuda K; Zendo T; Sugimoto S; Iwase T; Tajima A; Yamada S; Sonomoto K; Mizunoe Y
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5572-9. PubMed ID: 23979748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
    Escano J; Ravichandran A; Salamat B; Smith L
    Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nisin-A lantibiotic with immunomodulatory properties: A review.
    Małaczewska J; Kaczorek-Łukowska E
    Peptides; 2021 Mar; 137():170479. PubMed ID: 33359393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lantibiotics].
    Israil A
    Bacteriol Virusol Parazitol Epidemiol; 1992; 37(3-4):1-8. PubMed ID: 1340251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedical applications of nisin.
    Shin JM; Gwak JW; Kamarajan P; Fenno JC; Rickard AH; Kapila YL
    J Appl Microbiol; 2016 Jun; 120(6):1449-65. PubMed ID: 26678028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced VRE and MRSA colonisation and infection following sustained reduction in broad spectrum antibiotic use in a large tertiary hospital.
    Ferguson JK; Munnoch SA; Kozierowski K; Chiu S; Oldmeadow C
    Med J Aust; 2019 Aug; 211(3):126-127. PubMed ID: 31155720
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibiotic stewardship--state of the art].
    Carmeli Y
    Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S99-S100. PubMed ID: 25429544
    [No Abstract]   [Full Text] [Related]  

  • 9. [Do we really need new antibiotics?].
    Putensen C
    Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S83-4. PubMed ID: 25429536
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic.
    Huo L; van der Donk WA
    J Am Chem Soc; 2016 Apr; 138(16):5254-7. PubMed ID: 27074593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery.
    van Heel AJ; Kloosterman TG; Montalban-Lopez M; Deng J; Plat A; Baudu B; Hendriks D; Moll GN; Kuipers OP
    ACS Synth Biol; 2016 Oct; 5(10):1146-1154. PubMed ID: 27294279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Antibacterial Nisin⁻Peptoid Hybrids Using Click Methodology.
    Bolt HL; Kleijn LHJ; Martin NI; Cobb SL
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29958423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300.
    Thomsen TT; Mojsoska B; Cruz JC; Donadio S; Jenssen H; Løbner-Olesen A; Rewitz K
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5427-36. PubMed ID: 27381394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B.
    Dickman R; Mitchell SA; Figueiredo AM; Hansen DF; Tabor AB
    J Org Chem; 2019 Sep; 84(18):11493-11512. PubMed ID: 31464129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineering of the model lantibiotic nisin.
    Field D; Cotter PD; Ross RP; Hill C
    Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
    Li Q; Montalban-Lopez M; Kuipers OP
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commercial development and application of type A lantibiotics.
    Wilson-Stanford S; Smith L
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):175-85. PubMed ID: 21517737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lipidation and glycosylation on short cationic antimicrobial peptides.
    Grimsey E; Collis DWP; Mikut R; Hilpert K
    Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183195. PubMed ID: 32130974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why new antibiotics are not obviously useful now.
    Dubourg G; Abat C; Raoult D
    Int J Antimicrob Agents; 2017 May; 49(5):549-553. PubMed ID: 28104340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.